Duration: CME/CE Points: Faculty:
-
CME : 1.5

New Treatment Advances & Current Management Approaches in Acute Kidney Injury-Hepatorenal Syndrome (AKI-HRS).

Beginning Date: 01/23/2020
Ending Date: 12/31/2020

Target Audience:
This activity has been designed to meet the educational needs of hepatologists, gastroenterologists, hospitalists/intensive care specialists, nephrologists, nurse practitioners (NPs), physician assistants (PAs), nurses (RNs) and other healthcare professionals involved in the care of patients with Hepatorenal syndrome (HRS).

Accreditation:
Credit Designation:
Purdue University College of Pharmacy designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Educational Objectives:
Upon completion of this educational activity, participants should be able to:
• Define the types of HRS, its prevalence rates, and proposed pathophysiology
• Discuss the International Club of Ascites (ICA) criteria for the diagnosis and management of acute kidney injury (AKI) in cirrhosis and apply these criteria in clinical practice
• Review the clinical signs of HRS and recognize the differing treatment goals in HRS (i.e. long-term treatment improvement of liver function vs. short term improvement of kidney function)
• Recognize the need for approved therapies for HRS in the U.S. and apply recommended treatment strategies to clinical practice in the absence of these therapies
• Identify new advancements in the treatment of HRS

Additional details will be posted as soon as information is available.

Target Audience

Gastroenterology, Hepatology, Nephrology, Physician Assistants, Nurse Practitioner

Fees

Activity Fee : Fee Details will be updated soon
Interested

Specialties

Gastroenterology, Hepatology, Nephrology, Physician Assistants, Nurse Practitioner

Convert
Onsite to Virtual Conference

Market your online event to Million plus Healthcare professionals.

Recommended